Skip to content

Feasibility of a telemedicine intervention in patients with an OPAT - APAT DTB Proto evaluation

Feasibility of a telemedicine intervention in patients with an OPAT - APAT DTB Proto evaluation - Pilot eOPAT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030938
Enrollment
50
Registered
2023-08-16
Start date
2023-09-25
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

There are no consistent ICD-10 codes. There is currently no OPS.

Interventions

Group 1: Patients with an an OPAT receive in addition to routine care the eHealth application APAT DTB Proto as a support. The app enables the direct communication with healthcare providers. The featu

Sponsors

DTB GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Indication of an OPAT -Possession of a smartphone

Exclusion criteria

Exclusion criteria: -language barrier -haptic and cognitive limitations -active use of drugs

Design outcomes

Primary

MeasureTime frame
Which parameter has the highest significane: Quality of care (questionnaires ZUF-8, ZAPA) , quality of life (questionnaire promis-29) or adherence (questionnaire A-14)

Secondary

MeasureTime frame
• Usability of APAT DTB Proto app (SUS) • Complications and side effects caused by the antibiotic therapy • Sucessfull focus remediation • Reinfection with the same microorganism/s • Reduction of duration of hospitalization • Usability of external access to the veins (e.g. Picc-Line) • Developement of thrombosis in the external vein access system

Countries

Germany

Contacts

Public ContactWiebke Düttmann

Charité - Universitätsmedizin Berlin

wiebke.duettmann@charite.de030-450-614204

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026